Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol
about
Arbidol for preventing and treating influenza in adults and childrenEvaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverInfluenzaNew small-molecule drug design strategies for fighting resistant influenza AEmerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human ParechovirusStructure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivoMechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidolInhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutininCharacterization of potent fusion inhibitors of influenza virusAureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein HemagglutininProgress of small molecular inhibitors in the development of anti-influenza virus agents.Investigational hemagglutinin-targeted influenza virus inhibitors.New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusionFrom neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection.Emerging antiviral strategies to interfere with influenza virus entry.Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutininIndirect study of non-covalent protein complexes by MALDI mass spectrometry: Origins, advantages, and applications of the "intensity-fading" approach.Broad-spectrum antivirals against viral fusion.The delivery of arbidol by salt engineering: synthesis, physicochemical properties and pharmacokinetics.Molecular mechanism of respiratory syncytial virus fusion inhibitors.Influenza A virus entry inhibitors targeting the hemagglutinin.Development of novel entry inhibitors targeting emerging viruses.Pharmacokinetics, metabolism, and excretion of the antiviral drug arbidol in humans.Novel hemagglutinin-based influenza virus inhibitors.Characteristics of human infection with avian influenza viruses and development of new antiviral agents.Biomedical importance of indoles.Antiviral strategies against influenza virus: towards new therapeutic approaches.Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenza.Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped virusesThe Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study.Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin.A 4-week oral toxicity study of an antiviral drug combination consisting of arbidol and acetaminophen in rats.Characterization of an influenza virus pseudotyped with Ebolavirus glycoprotein.Structural insights into the design of novel anti-influenza therapies.Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses.Synthesis and evaluation of thalidomide and phthalimide esters as antitumor agents.
P2860
Q24186818-44165BE3-33E5-45AA-8E38-4501BBB60E81Q27457152-37A3F0D2-094B-4E88-A2EB-8D3BC3FF4B06Q28066188-6133C5F0-F7FA-4061-AC23-05D00A6FB0BDQ28080554-0608E07A-69BA-426F-9640-3FD4C30F7814Q28085230-2BA06308-63DE-4B31-85DB-65968031F951Q28476470-516A2522-1A11-4939-9B8D-09DECBFE02D2Q28476811-4B43D6DB-659A-4B62-88A9-8DEB5C0C4F2BQ28478448-43610393-B6E8-4250-9E25-8BA108F34785Q28544971-73FC6660-00B5-4218-8CF6-570A2A98F144Q28550191-39DA6D55-D79B-4B7C-B53B-B04367BAB9D9Q30234943-F5A05635-5A3C-4DE5-BB52-90A4425B6EE7Q30240175-033E127D-C2F5-4B94-ACD3-E7EB943C685CQ30355297-56B95100-E049-4D61-9DFD-33202451AA34Q30363724-404E8821-63DE-43EB-94F8-E345FBFD1811Q30396717-F1A79517-809F-43E3-B287-403002D2E6C4Q30431968-FE6B8007-249F-404F-9B7F-CDA15719B2EDQ30432421-474B66AD-6686-4AA3-920F-D8E4ED5A5151Q33826751-2B2246FF-593D-430F-8495-A65654C54C7EQ35739405-4A005A42-3ADD-4251-94D7-6F30B3EE821AQ36010083-49AB6B26-6305-4987-8CE6-7498F252D5E1Q36105894-CA7C7BE8-EA45-4378-B2CC-F2E37C627DD6Q36517337-D2B5381C-B25F-4A29-9102-B0C637192DE4Q36586898-62EF8E8D-FA85-4A9F-B8DB-0DE290AC1C25Q36655280-2352A85A-E7CB-4D5E-8569-ACB074590F59Q36757686-50B03D4E-D11D-4536-9535-0F94CA3E29ADQ37105496-8E6795FC-CF11-4302-B318-E5ED7EA57A1CQ37217863-4840F6A6-131A-4E77-B5DF-B6320D3BE2E1Q38112598-5C36B307-BEF9-4EA7-AA75-51FF31AAE911Q38202012-716131A3-FAB1-4302-9FFF-A22AB92E8DEAQ38384758-00693E61-987E-4D91-ADFE-B386242AE016Q39323887-4DE2054C-D84F-4D72-A4A6-91DDD38FCB06Q39452637-8C598845-6BB1-42C0-B890-EA2131AED023Q39788993-0DB9CA56-53C0-4F4F-8061-690627AFC755Q40026277-F0385132-F5D2-4910-88A3-6FCE89105EDCQ40130250-6EB981DC-122B-4F5A-845D-11A3B80F3E6AQ43080241-AD99F9A9-10F7-4361-84EA-29786877182CQ45323703-A7BD3C40-A5DF-41D2-9F08-84039FCD8829Q48113181-B77556A6-6D9D-445E-A3FD-7CF369B034A9Q53693795-F042DB31-A3D4-4842-A691-42402CC10177Q53839555-28515D74-86FC-4D66-B271-F0A7D35ED4A8
P2860
Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@ast
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@en
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@nl
type
label
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@ast
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@en
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@nl
prefLabel
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@ast
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@en
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@nl
P2093
P1433
P1476
Characteristics of arbidol-res ...... ti-influenza action of arbidol
@en
P2093
Alan J Hay
Irina A Leneva
Rupert J Russell
Yury S Boriskin
P304
P356
10.1016/J.ANTIVIRAL.2008.10.009
P407
P577
2009-02-01T00:00:00Z